ORG Home NVM Corporate Home Investors
 
 

Clinical Medicine

Given trends such as telemedicine and "evidence based" healthcare management, Radiologists, Neurologists, and Psychiatrists will eventually come to rely on quantitative neuromorphometrics not only to improve, but also to document both the diagnosis and measurement of treatment response.

The size of the clinical market can also be expected to increase as useful diagnostics appear in areas such as Schizophrenia and ADHD and will further increase as the population ages and larger numbers of people are affected by Alzheimer’s Disease.

< -- back                  next -- >

 
 ©1998-2007 Neuromorphometrics, Inc. All rights reserved. ORG HomeNVM Corporate Home Investors